معرفی
Adam Y Lin is an Assistant Professor in Medicine (Hematology and Oncology) at Northwestern University, affiliated with the Robert H. Lurie Comprehensive Cancer Center and the Center for Human Immunobiology. His work focuses on advancing CAR-T cell therapies, immunotherapies, and nanotechnology-based cancer treatments, particularly targeting hematologic malignancies like lymphoma and AML. He investigates mechanisms such as ferroptosis induction, receptor-targeted drug delivery, and overcoming immunotherapy resistance through lipid nanoparticle systems.
Research Interests: His studies integrate immunobiology, nano-engineered therapies, and precision medicine to address challenges in CAR-T cell therapy toxicity, tumor microenvironment modulation, and drug delivery optimization. Key themes include:
- Development of lipid nanoparticles for ferroptosis-inducing agents
- Targeting scavenger receptors (SR-B1) in cholesterol-dependent cancers
- Clinical outcomes of CAR-T therapy in aggressive lymphomas and post-transplant patients
- Synergy between photothermal therapy and adoptive T cell transfer
Recent Work Trends: Over 2023-2025, his publications emphasize real-world CAR-T efficacy, secondary malignancies post-CAR-T, and novel nanoparticle formulations for targeted cancer therapies.
Awards: No specific honors listed in the provided text.
Grants & Advising: While specific grants aren't detailed, his research is likely supported by NIH/National Cancer Institute grants given his focus areas. No students listed in the text.
Labs/Teams: Collaborates through the Center for Human Immunobiology and NUCATS Institute, focusing on translational research bridging nanotechnology and hematology/oncology clinical applications.
